What does ICD-10 code C92.2 mean?

ICD-10 code C92.2 is the standardized code used for atypical chronic myeloid leukemia, bcr/abl-negative in medical records and coding systems.

When is ICD-10 code C92.2 used?

Doctors, hospitals, and insurers may use ICD-10 code C92.2 when recording atypical chronic myeloid leukemia, bcr/abl-negative in a standardized format. This entry may also act as a broader category that points toward more specific child codes.

Does ICD-10 code C92.2 confirm a diagnosis?

No. A code helps standardize documentation and claims, but it should not be read as a substitute for a clinician's full assessment.

ICD10

ICD-10 Code C92.2: Atypical chronic myeloid leukemia, BCR/ABL-negative

Name: ICD-10 Code C92.2: Atypical chronic myeloid leukemia, BCR/ABL-negative
Creator: HealthAssure Clinical Team
Published: 2026-05-26T12:46:38.762Z

C92.2 is an ICD-10 diagnosis entry used to group records related to Atypical chronic myeloid leukemia, BCR/ABL-negative. You may see this entry in coding references, medical records, or claims workflows when a broader diagnosis category is being reviewed before a more specific code is chosen. ICD-10 entries help standardize how diagnoses are organized for coding, reporting, analytics, and documentation. This code sits within the broader ICD-10 area for Neoplasms (C00-D49).

Reviewed by HealthAssure Clinical TeamUpdated 26 May 2026

What is this code?

ICD-10 entries help standardize how diagnoses are organized for coding, reporting, analytics, and documentation. This code sits within the broader ICD-10 area for Neoplasms (C00-D49).

When is it used?

May be used when a clinician documents atypical chronic myeloid leukemia, bcr/abl-negative in a patient's medical record.
May appear in hospital records, claims, referrals, and clinical documentation.
This code may act more like a grouping or parent code, so a more specific child code may be used in final documentation when available.

What it does not mean

A code alone does not explain severity, treatment plan, or outcome.
A medical code should not be treated as a substitute for a doctor's diagnosis or advice.
This entry may represent a broader category rather than the most specific billable code.

Code hierarchy

chapter

2Neoplasms (C00-D49)

block

C00-C96Malignant neoplasms

block

C81-C96Malignant neoplasms of lymphoid, hematopoietic and related tissue

Where you may see this code

You may see this entry in coding references, medical records, or claims workflows when a broader diagnosis category is being reviewed before a more specific code is chosen.

Related specialists

OncologistGeneral Physician

Sibling codes

C92.0Acute myeloblastic leukemia C92.1Chronic myeloid leukemia, BCR/ABL-positive C92.3Myeloid sarcoma C92.4Acute promyelocytic leukemia C92.5Acute myelomonocytic leukemia C92.6Acute myeloid leukemia with 11q23-abnormality C92.AAcute myeloid leukemia with multilineage dysplasia C92.ZOther myeloid leukemia C92.9Myeloid leukemia, unspecified

Mapped diagnoses and classifications

SNOMED_CT 413389003high

Accelerated phase chronic myeloid leukemia

Source: SNOMED International ICD-10 map

SNOMED_CT 277589003high

Myelodysplastic/myeloproliferative neoplasm with neutrophilia

Source: SNOMED International ICD-10 map

Coding guidelines

Compatibility

Legacy code aligns to an official FY 2026 category. Frontend should resolve to the official category page and surface the billable child codes.

Legacy codes

C92.2

Replacement codes

C92.20 — Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remissionC92.21 — Atypical chronic myeloid leukemia, BCR/ABL-negative, in remissionC92.22 — Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse

Common synonyms

Atypical chronic myeloid leukemia, BCR/ABL-negative

Frequently asked questions

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from ICD-10. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.